nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—peripheral nervous system neoplasm	0.244	1	CbGaD
Pimozide—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0469	0.0985	CbGbCtD
Pimozide—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0469	0.0985	CbGbCtD
Pimozide—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0389	0.0818	CbGbCtD
Pimozide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0352	0.0739	CbGbCtD
Pimozide—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0282	0.0591	CbGbCtD
Pimozide—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0246	0.0517	CbGbCtD
Pimozide—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0246	0.0517	CbGbCtD
Pimozide—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0225	0.0473	CbGbCtD
Pimozide—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0215	0.0452	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0215	0.0452	CbGbCtD
Pimozide—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0191	0.04	CbGbCtD
Pimozide—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0171	0.0358	CbGbCtD
Pimozide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0162	0.0339	CbGbCtD
Pimozide—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0148	0.0311	CbGbCtD
Pimozide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0148	0.031	CbGbCtD
Pimozide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0137	0.0288	CbGbCtD
Pimozide—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.011	0.0231	CbGbCtD
Pimozide—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0105	0.0221	CbGbCtD
Pimozide—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00981	0.0206	CbGbCtD
Pimozide—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00964	0.0202	CbGbCtD
Pimozide—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00657	0.0138	CbGbCtD
Pimozide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0063	0.0132	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00619	0.013	CbGbCtD
Pimozide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00577	0.0121	CbGbCtD
Pimozide—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00567	0.112	CbGeAlD
Pimozide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00394	0.00827	CbGbCtD
Pimozide—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.0034	0.0671	CbGeAlD
Pimozide—HTR6—ganglion—peripheral nervous system neoplasm	0.00258	0.0508	CbGeAlD
Pimozide—CALM1—cranial nerve—peripheral nervous system neoplasm	0.00243	0.0478	CbGeAlD
Pimozide—CALM2—pons—peripheral nervous system neoplasm	0.00241	0.0474	CbGeAlD
Pimozide—CALM1—pons—peripheral nervous system neoplasm	0.0024	0.0472	CbGeAlD
Pimozide—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00207	0.0409	CbGeAlD
Pimozide—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00194	0.0382	CbGeAlD
Pimozide—OPRM1—nerve—peripheral nervous system neoplasm	0.00172	0.0339	CbGeAlD
Pimozide—OPRM1—ganglion—peripheral nervous system neoplasm	0.0017	0.0335	CbGeAlD
Pimozide—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00148	0.0291	CbGeAlD
Pimozide—HTR2A—pons—peripheral nervous system neoplasm	0.00146	0.0288	CbGeAlD
Pimozide—HTR1A—ganglion—peripheral nervous system neoplasm	0.00125	0.0247	CbGeAlD
Pimozide—CALM2—nerve—peripheral nervous system neoplasm	0.00125	0.0246	CbGeAlD
Pimozide—CALM1—nerve—peripheral nervous system neoplasm	0.00124	0.0245	CbGeAlD
Pimozide—CALM2—ganglion—peripheral nervous system neoplasm	0.00123	0.0243	CbGeAlD
Pimozide—CALM1—ganglion—peripheral nervous system neoplasm	0.00123	0.0242	CbGeAlD
Pimozide—DRD2—nerve—peripheral nervous system neoplasm	0.00115	0.0226	CbGeAlD
Pimozide—DRD2—ganglion—peripheral nervous system neoplasm	0.00113	0.0223	CbGeAlD
Pimozide—CACNA1G—cerebellum—peripheral nervous system neoplasm	0.000806	0.0159	CbGeAlD
Pimozide—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.000771	0.0152	CbGeAlD
Pimozide—HTR2A—nerve—peripheral nervous system neoplasm	0.000757	0.0149	CbGeAlD
Pimozide—HTR2A—ganglion—peripheral nervous system neoplasm	0.000748	0.0147	CbGeAlD
Pimozide—OPRM1—brainstem—peripheral nervous system neoplasm	0.000739	0.0146	CbGeAlD
Pimozide—CALM3—parotid gland—peripheral nervous system neoplasm	0.000728	0.0143	CbGeAlD
Pimozide—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000606	0.0119	CbGeAlD
Pimozide—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.000603	0.0119	CbGeAlD
Pimozide—CALM2—parotid gland—peripheral nervous system neoplasm	0.000571	0.0113	CbGeAlD
Pimozide—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000549	0.0108	CbGeAlD
Pimozide—HTR1A—brainstem—peripheral nervous system neoplasm	0.000545	0.0107	CbGeAlD
Pimozide—Ezetimibe—ABCB1—peripheral nervous system neoplasm	0.00054	0.297	CrCbGaD
Pimozide—Astemizole—ABCB1—peripheral nervous system neoplasm	0.00054	0.297	CrCbGaD
Pimozide—CALM2—brainstem—peripheral nervous system neoplasm	0.000536	0.0106	CbGeAlD
Pimozide—CALM1—brainstem—peripheral nervous system neoplasm	0.000534	0.0105	CbGeAlD
Pimozide—OPRK1—cerebellum—peripheral nervous system neoplasm	0.000512	0.0101	CbGeAlD
Pimozide—DRD2—brainstem—peripheral nervous system neoplasm	0.000493	0.00971	CbGeAlD
Pimozide—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00044	0.00867	CbGeAlD
Pimozide—Fexofenadine—ABCB1—peripheral nervous system neoplasm	0.000384	0.212	CrCbGaD
Pimozide—Domperidone—ABCB1—peripheral nervous system neoplasm	0.000351	0.193	CrCbGaD
Pimozide—CALM3—cerebellum—peripheral nervous system neoplasm	0.000337	0.00663	CbGeAlD
Pimozide—HTR2A—brainstem—peripheral nervous system neoplasm	0.000325	0.00641	CbGeAlD
Pimozide—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000296	0.00584	CbGeAlD
Pimozide—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000269	0.0053	CbGeAlD
Pimozide—CALM2—cerebellum—peripheral nervous system neoplasm	0.000264	0.00521	CbGeAlD
Pimozide—CALM1—cerebellum—peripheral nervous system neoplasm	0.000263	0.00518	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.0018	CcSEcCtD
Pimozide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000255	0.0018	CcSEcCtD
Pimozide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.00178	CcSEcCtD
Pimozide—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000253	0.00178	CcSEcCtD
Pimozide—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000252	0.00178	CcSEcCtD
Pimozide—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00177	CcSEcCtD
Pimozide—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000251	0.00177	CcSEcCtD
Pimozide—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000251	0.00177	CcSEcCtD
Pimozide—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000248	0.00174	CcSEcCtD
Pimozide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000247	0.00174	CcSEcCtD
Pimozide—DRD2—cerebellum—peripheral nervous system neoplasm	0.000243	0.00479	CbGeAlD
Pimozide—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000243	0.00171	CcSEcCtD
Pimozide—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00171	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.0017	CcSEcCtD
Pimozide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.0017	CcSEcCtD
Pimozide—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000241	0.0017	CcSEcCtD
Pimozide—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000241	0.00474	CbGeAlD
Pimozide—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00169	CcSEcCtD
Pimozide—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000239	0.00472	CbGeAlD
Pimozide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00169	CcSEcCtD
Pimozide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00168	CcSEcCtD
Pimozide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000238	0.00167	CcSEcCtD
Pimozide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000235	0.00166	CcSEcCtD
Pimozide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000235	0.00165	CcSEcCtD
Pimozide—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00164	CcSEcCtD
Pimozide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000233	0.00164	CcSEcCtD
Pimozide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000233	0.00164	CcSEcCtD
Pimozide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000233	0.00164	CcSEcCtD
Pimozide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000232	0.00163	CcSEcCtD
Pimozide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.00163	CcSEcCtD
Pimozide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00023	0.00162	CcSEcCtD
Pimozide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00023	0.00162	CcSEcCtD
Pimozide—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.00162	CcSEcCtD
Pimozide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00023	0.00162	CcSEcCtD
Pimozide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00023	0.00162	CcSEcCtD
Pimozide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00023	0.00162	CcSEcCtD
Pimozide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000227	0.0016	CcSEcCtD
Pimozide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000227	0.0016	CcSEcCtD
Pimozide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000226	0.00159	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00158	CcSEcCtD
Pimozide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000224	0.00158	CcSEcCtD
Pimozide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000223	0.00157	CcSEcCtD
Pimozide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.00157	CcSEcCtD
Pimozide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000223	0.00157	CcSEcCtD
Pimozide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000223	0.00157	CcSEcCtD
Pimozide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000222	0.00156	CcSEcCtD
Pimozide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00155	CcSEcCtD
Pimozide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00022	0.00155	CcSEcCtD
Pimozide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.00154	CcSEcCtD
Pimozide—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00154	CcSEcCtD
Pimozide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000218	0.00153	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00153	CcSEcCtD
Pimozide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000217	0.00153	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000216	0.00152	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00152	CcSEcCtD
Pimozide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000215	0.00151	CcSEcCtD
Pimozide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000215	0.00151	CcSEcCtD
Pimozide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000215	0.00151	CcSEcCtD
Pimozide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00151	CcSEcCtD
Pimozide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.0015	CcSEcCtD
Pimozide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000211	0.00149	CcSEcCtD
Pimozide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00148	CcSEcCtD
Pimozide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000208	0.00147	CcSEcCtD
Pimozide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000207	0.00146	CcSEcCtD
Pimozide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000207	0.00146	CcSEcCtD
Pimozide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000207	0.00146	CcSEcCtD
Pimozide—Rash—Topotecan—peripheral nervous system neoplasm	0.000207	0.00146	CcSEcCtD
Pimozide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000207	0.00145	CcSEcCtD
Pimozide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000206	0.00145	CcSEcCtD
Pimozide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000206	0.00145	CcSEcCtD
Pimozide—Headache—Topotecan—peripheral nervous system neoplasm	0.000205	0.00145	CcSEcCtD
Pimozide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000205	0.00144	CcSEcCtD
Pimozide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000205	0.00144	CcSEcCtD
Pimozide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000205	0.00144	CcSEcCtD
Pimozide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00144	CcSEcCtD
Pimozide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000205	0.00144	CcSEcCtD
Pimozide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000205	0.00144	CcSEcCtD
Pimozide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000204	0.00144	CcSEcCtD
Pimozide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000204	0.00144	CcSEcCtD
Pimozide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000204	0.00144	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00144	CcSEcCtD
Pimozide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000204	0.00143	CcSEcCtD
Pimozide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000204	0.00143	CcSEcCtD
Pimozide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000204	0.00143	CcSEcCtD
Pimozide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000203	0.00143	CcSEcCtD
Pimozide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00143	CcSEcCtD
Pimozide—Rash—Melphalan—peripheral nervous system neoplasm	0.000202	0.00142	CcSEcCtD
Pimozide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000202	0.00142	CcSEcCtD
Pimozide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000201	0.00141	CcSEcCtD
Pimozide—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00141	CcSEcCtD
Pimozide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0002	0.00141	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000199	0.0014	CcSEcCtD
Pimozide—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000198	0.0014	CcSEcCtD
Pimozide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000196	0.00138	CcSEcCtD
Pimozide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.00138	CcSEcCtD
Pimozide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000195	0.00137	CcSEcCtD
Pimozide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000193	0.00136	CcSEcCtD
Pimozide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000193	0.00136	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00135	CcSEcCtD
Pimozide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.00134	CcSEcCtD
Pimozide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000191	0.00134	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00134	CcSEcCtD
Pimozide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000188	0.00132	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00132	CcSEcCtD
Pimozide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000187	0.00132	CcSEcCtD
Pimozide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000186	0.00131	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00131	CcSEcCtD
Pimozide—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000184	0.00363	CbGeAlD
Pimozide—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00129	CcSEcCtD
Pimozide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000183	0.00129	CcSEcCtD
Pimozide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00129	CcSEcCtD
Pimozide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000182	0.00128	CcSEcCtD
Pimozide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000181	0.00128	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00127	CcSEcCtD
Pimozide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00018	0.00127	CcSEcCtD
Pimozide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.00124	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00124	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00123	CcSEcCtD
Pimozide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.00123	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00122	CcSEcCtD
Pimozide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00122	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00121	CcSEcCtD
Pimozide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000171	0.0012	CcSEcCtD
Pimozide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00017	0.0012	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00119	CcSEcCtD
Pimozide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000169	0.00119	CcSEcCtD
Pimozide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.00119	CcSEcCtD
Pimozide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000168	0.00118	CcSEcCtD
Pimozide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000167	0.00118	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.00117	CcSEcCtD
Pimozide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000166	0.00117	CcSEcCtD
Pimozide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000165	0.00116	CcSEcCtD
Pimozide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.00115	CcSEcCtD
Pimozide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000162	0.00114	CcSEcCtD
Pimozide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00114	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00114	CcSEcCtD
Pimozide—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00016	0.00316	CbGeAlD
Pimozide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00112	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00112	CcSEcCtD
Pimozide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00111	CcSEcCtD
Pimozide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000157	0.00111	CcSEcCtD
Pimozide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.0011	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.0011	CcSEcCtD
Pimozide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Pimozide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.00109	CcSEcCtD
Pimozide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.00109	CcSEcCtD
Pimozide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000153	0.00108	CcSEcCtD
Pimozide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000151	0.00106	CcSEcCtD
Pimozide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000151	0.00106	CcSEcCtD
Pimozide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00106	CcSEcCtD
Pimozide—Rash—Vincristine—peripheral nervous system neoplasm	0.00015	0.00105	CcSEcCtD
Pimozide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00015	0.00105	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00105	CcSEcCtD
Pimozide—Headache—Vincristine—peripheral nervous system neoplasm	0.000149	0.00105	CcSEcCtD
Pimozide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.00103	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00103	CcSEcCtD
Pimozide—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000146	0.00288	CbGeAlD
Pimozide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00103	CcSEcCtD
Pimozide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000144	0.00101	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000999	CcSEcCtD
Pimozide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000141	0.000993	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000992	CcSEcCtD
Pimozide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000138	0.000972	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000972	CcSEcCtD
Pimozide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000136	0.000958	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000953	CcSEcCtD
Pimozide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00094	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000936	CcSEcCtD
Pimozide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000932	CcSEcCtD
Pimozide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000931	CcSEcCtD
Pimozide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000132	0.000927	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000924	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000918	CcSEcCtD
Pimozide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000127	0.000896	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000894	CcSEcCtD
Pimozide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000878	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000877	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000866	CcSEcCtD
Pimozide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000122	0.000861	CcSEcCtD
Pimozide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00086	CcSEcCtD
Pimozide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000855	CcSEcCtD
Pimozide—Rash—Etoposide—peripheral nervous system neoplasm	0.000121	0.000854	CcSEcCtD
Pimozide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000121	0.000853	CcSEcCtD
Pimozide—Headache—Etoposide—peripheral nervous system neoplasm	0.000121	0.000849	CcSEcCtD
Pimozide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000834	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000833	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000828	CcSEcCtD
Pimozide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000822	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000818	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000811	CcSEcCtD
Pimozide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000806	CcSEcCtD
Pimozide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000114	0.000805	CcSEcCtD
Pimozide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000803	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000796	CcSEcCtD
Pimozide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000792	CcSEcCtD
Pimozide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000792	CcSEcCtD
Pimozide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000791	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000787	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000775	CcSEcCtD
Pimozide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000772	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00077	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000761	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000757	CcSEcCtD
Pimozide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000747	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000746	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000745	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000743	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000741	CcSEcCtD
Pimozide—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000105	0.00207	CbGeAlD
Pimozide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000737	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000734	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000733	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000733	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000728	CcSEcCtD
Pimozide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000724	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000717	CcSEcCtD
Pimozide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000709	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000692	CcSEcCtD
Pimozide—Shock—Doxorubicin—peripheral nervous system neoplasm	9.82e-05	0.000691	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000689	CcSEcCtD
Pimozide—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.75e-05	0.000687	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000686	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000682	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000679	CcSEcCtD
Pimozide—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000675	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.00067	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.00066	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000656	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000655	CcSEcCtD
Pimozide—Constipation—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000649	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.00064	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000635	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000625	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000611	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000606	CcSEcCtD
Pimozide—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000603	CcSEcCtD
Pimozide—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000601	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000558	CcSEcCtD
Pimozide—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000545	CcSEcCtD
Pimozide—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000537	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000519	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000504	CcSEcCtD
Pimozide—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000502	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000497	CcSEcCtD
Pimozide—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000483	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000481	CcSEcCtD
Pimozide—Rash—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000479	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000478	CcSEcCtD
Pimozide—Headache—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000476	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000465	CcSEcCtD
Pimozide—Nausea—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000451	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000447	CcSEcCtD
Pimozide—Rash—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000443	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000443	CcSEcCtD
Pimozide—Headache—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.00044	CcSEcCtD
Pimozide—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000417	CcSEcCtD
Pimozide—CALM3—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000127	CbGpPWpGaD
Pimozide—CALM2—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000127	CbGpPWpGaD
Pimozide—CALM1—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000127	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.000127	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.07e-05	0.000126	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000126	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000125	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000125	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.06e-05	0.000125	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000125	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000125	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.06e-05	0.000124	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.000124	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.05e-05	0.000123	CbGpPWpGaD
Pimozide—CALM2—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.05e-05	0.000123	CbGpPWpGaD
Pimozide—CALM1—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.05e-05	0.000123	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.04e-05	0.000123	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000122	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.04e-05	0.000122	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	0.000122	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.04e-05	0.000122	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.03e-05	0.000122	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.03e-05	0.000122	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.02e-05	0.00012	CbGpPWpGaD
Pimozide—CALM3—Immune System—PTPN11—peripheral nervous system neoplasm	1e-05	0.000118	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—NRAS—peripheral nervous system neoplasm	1e-05	0.000118	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1e-05	0.000118	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.95e-06	0.000117	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.91e-06	0.000117	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.84e-06	0.000116	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.84e-06	0.000116	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.8e-06	0.000115	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	9.77e-06	0.000115	CbGpPWpGaD
Pimozide—CALM2—Immune System—PTPN11—peripheral nervous system neoplasm	9.71e-06	0.000114	CbGpPWpGaD
Pimozide—CALM1—Immune System—PTPN11—peripheral nervous system neoplasm	9.71e-06	0.000114	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.66e-06	0.000114	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.62e-06	0.000113	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	9.62e-06	0.000113	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.34e-06	0.00011	CbGpPWpGaD
Pimozide—CALM3—Disease—PTPN11—peripheral nervous system neoplasm	9.27e-06	0.000109	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.24e-06	0.000109	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.21e-06	0.000108	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.1e-06	0.000107	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.05e-06	0.000107	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.03e-06	0.000106	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.03e-06	0.000106	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.98e-06	0.000106	CbGpPWpGaD
Pimozide—CALM1—Disease—PTPN11—peripheral nervous system neoplasm	8.96e-06	0.000106	CbGpPWpGaD
Pimozide—CALM2—Disease—PTPN11—peripheral nervous system neoplasm	8.96e-06	0.000106	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.9e-06	0.000105	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.85e-06	0.000104	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—peripheral nervous system neoplasm	8.8e-06	0.000104	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.8e-06	0.000104	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.77e-06	0.000103	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	8.67e-06	0.000102	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—peripheral nervous system neoplasm	8.52e-06	0.0001	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—peripheral nervous system neoplasm	8.52e-06	0.0001	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	8.51e-06	0.0001	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.46e-06	9.97e-05	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—HRAS—peripheral nervous system neoplasm	8.42e-06	9.92e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.4e-06	9.89e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.28e-06	9.76e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	8.28e-06	9.75e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.2e-06	9.66e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.15e-06	9.6e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—HRAS—peripheral nervous system neoplasm	8.14e-06	9.59e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—HRAS—peripheral nervous system neoplasm	8.14e-06	9.59e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.09e-06	9.52e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	8.04e-06	9.47e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.04e-06	9.46e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	7.97e-06	9.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.96e-06	9.37e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.94e-06	9.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.94e-06	9.35e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—ERBB2—peripheral nervous system neoplasm	7.93e-06	9.34e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.83e-06	9.22e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.82e-06	9.21e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.81e-06	9.2e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.81e-06	9.19e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.8e-06	9.19e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.73e-06	9.1e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.67e-06	9.04e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—ERBB2—peripheral nervous system neoplasm	7.67e-06	9.04e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	7.67e-06	9.04e-05	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.59e-06	8.94e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	7.58e-06	8.93e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.52e-06	8.86e-05	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.52e-06	8.85e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.46e-06	8.78e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.45e-06	8.77e-05	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	7.43e-06	8.75e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.35e-06	8.66e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	7.33e-06	8.64e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	7.33e-06	8.64e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	7.32e-06	8.62e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	7.28e-06	8.57e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	7.19e-06	8.47e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	7.19e-06	8.47e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.15e-06	8.42e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	7.08e-06	8.34e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	7.08e-06	8.34e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	7.04e-06	8.29e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	7.04e-06	8.29e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.95e-06	8.18e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.89e-06	8.12e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.85e-06	8.06e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.83e-06	8.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.79e-06	8e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.76e-06	7.96e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.74e-06	7.93e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.69e-06	7.88e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.63e-06	7.81e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.6e-06	7.78e-05	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.55e-06	7.72e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.49e-06	7.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.49e-06	7.64e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.48e-06	7.63e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.47e-06	7.62e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	6.47e-06	7.62e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	6.43e-06	7.57e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.39e-06	7.52e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.39e-06	7.52e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.39e-06	7.52e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.3e-06	7.42e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.28e-06	7.39e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.28e-06	7.39e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.28e-06	7.39e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.24e-06	7.35e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	6.22e-06	7.32e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	6.22e-06	7.32e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.18e-06	7.28e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.16e-06	7.26e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.07e-06	7.14e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	6.03e-06	7.11e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.95e-06	7.01e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.92e-06	6.97e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.87e-06	6.91e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	5.84e-06	6.87e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	5.84e-06	6.87e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.82e-06	6.85e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.81e-06	6.85e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.81e-06	6.84e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.75e-06	6.77e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.71e-06	6.73e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.7e-06	6.72e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.7e-06	6.71e-05	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.66e-06	6.67e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.65e-06	6.65e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.62e-06	6.62e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.61e-06	6.6e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.6e-06	6.59e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—NRAS—peripheral nervous system neoplasm	5.57e-06	6.56e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.56e-06	6.54e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.51e-06	6.48e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.46e-06	6.43e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.44e-06	6.41e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NRAS—peripheral nervous system neoplasm	5.39e-06	6.35e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NRAS—peripheral nervous system neoplasm	5.39e-06	6.35e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.38e-06	6.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.22e-06	6.15e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.21e-06	6.14e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—peripheral nervous system neoplasm	5.19e-06	6.11e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.14e-06	6.05e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.13e-06	6.04e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.13e-06	6.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.12e-06	6.03e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.07e-06	5.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.05e-06	5.94e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—peripheral nervous system neoplasm	5.02e-06	5.91e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—peripheral nervous system neoplasm	5.02e-06	5.91e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.96e-06	5.84e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.96e-06	5.84e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.83e-06	5.69e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.82e-06	5.68e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.82e-06	5.67e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.78e-06	5.63e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.78e-06	5.62e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.75e-06	5.59e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.7e-06	5.54e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.69e-06	5.52e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.67e-06	5.5e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.67e-06	5.5e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.65e-06	5.48e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.61e-06	5.43e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.61e-06	5.43e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.57e-06	5.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.5e-06	5.3e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.5e-06	5.3e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.45e-06	5.24e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	4.41e-06	5.2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.38e-06	5.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.37e-06	5.14e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.3e-06	5.06e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	4.27e-06	5.03e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	4.27e-06	5.03e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.27e-06	5.02e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	4.19e-06	4.93e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.16e-06	4.9e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.13e-06	4.86e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.13e-06	4.86e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—peripheral nervous system neoplasm	4.08e-06	4.8e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.07e-06	4.79e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.03e-06	4.75e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.98e-06	4.69e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—peripheral nervous system neoplasm	3.94e-06	4.64e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—peripheral nervous system neoplasm	3.94e-06	4.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.9e-06	4.59e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	3.9e-06	4.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.77e-06	4.44e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.77e-06	4.44e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	3.77e-06	4.44e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	3.77e-06	4.44e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.65e-06	4.3e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.63e-06	4.28e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—peripheral nervous system neoplasm	3.6e-06	4.24e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.6e-06	4.23e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.59e-06	4.23e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.53e-06	4.16e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.52e-06	4.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.52e-06	4.14e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.51e-06	4.14e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.49e-06	4.12e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—peripheral nervous system neoplasm	3.48e-06	4.1e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—peripheral nervous system neoplasm	3.48e-06	4.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.44e-06	4.05e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.43e-06	4.04e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.38e-06	3.98e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.09e-06	3.63e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.04e-06	3.58e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	3.03e-06	3.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.03e-06	3.57e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	3.03e-06	3.56e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	3.01e-06	3.55e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.98e-06	3.51e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.98e-06	3.51e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	2.92e-06	3.43e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	2.92e-06	3.43e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.89e-06	3.4e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.89e-06	3.4e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.85e-06	3.36e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.76e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.76e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.52e-06	2.97e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.44e-06	2.87e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.44e-06	2.87e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	2.34e-06	2.76e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.28e-06	2.69e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.15e-06	2.53e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-06	2.15e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-06	1.66e-05	CbGpPWpGaD
